Implications of baseline glycemic control by plasma glycated hemoglobin A1c on adverse outcomes in patients with coronary heart disease and type 2 diabetes mellitus: Results from the PROMISE study

Implications of baseline glycemic control by plasma glycated hemoglobin A1c on adverse outcomes in patients with coronary heart disease and type 2 diabetes mellitus: Results from the PROMISE study

Background: The optimal glycosylated hemoglobin (HbA1c) target in type 2 diabetes mellitus (T2DM) patients remains controversial, especially in patients with concomitant coronary heart disease (CHD). This study aimed to investigate the correlation between baseline HbA1c and long-term prognosis in CH...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiao-Fang Tang, Qin-Xue Li, Ya-Ling Han, Xiao-Zeng Wang, Ying Song, Zheng Zhang, Jing-Jing Xu, Zhen-Yu Liu, Yan Chen, Yong-Zhen Zhang, Pei Zhu, Xiao-Gang Guo, Lin Jiang, Zhi-Fang Wang, Ru Liu, Qing-Sheng Wang, Yi Yao, Ying-Qing Feng, Xue-Yan Zhao, Jin-Qing Yuan
Format: Article
Language:English
Published: Elsevier 2024-11-01
Series:Heliyon
Subjects:
Coronary heart disease
Type 2 diabetes mellitus
Glycemic control
Glycosylated hemoglobin
Adverse outcomes
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024157799
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2405844024157799

Similar Items